Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Roche Holding AG (RHHVF)

Tipranks - Wed Mar 11, 9:06PM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IQVIA Holdings (IQVResearch Report) and Roche Holding AG (RHHVFResearch Report) with bullish sentiments.

Claim 70% Off TipRanks Premium

IQVIA Holdings (IQV)

RBC Capital analyst Ryan Halsted maintained a Buy rating on IQVIA Holdings yesterday and set a price target of $221.00. The company’s shares closed last Tuesday at $170.93.

According to TipRanks.com, Halsted is a 1-star analyst with an average return of -5.0% and a 34.8% success rate. Halsted covers the Healthcare sector, focusing on stocks such as Privia Health Group, Healthcare Services, and Medpace Holdings. ;'>

The word on The Street in general, suggests a Strong Buy analyst consensus rating for IQVIA Holdings with a $229.64 average price target, a 28.9% upside from current levels. In a report issued on February 23, TipRanks – PerPlexity also upgraded the stock to Buy with a $191.00 price target.

See today’s best-performing stocks on TipRanks >>

Roche Holding AG (RHHVF)

Kepler Capital analyst David Evans maintained a Buy rating on Roche Holding AG on March 9 and set a price target of CHF415.00. The company’s shares closed last Tuesday at $438.21.

Evans has an average return of 23.5% when recommending Roche Holding AG. ;'>

According to TipRanks.com, Evans is ranked #6247 out of 12122 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Roche Holding AG with a $451.37 average price target, implying a 5.7% upside from current levels. In a report issued on March 3, Barclays also maintained a Buy rating on the stock with a CHF410.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.